R. E. Esveldt

657 total citations
13 papers, 414 citations indexed

About

R. E. Esveldt is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, R. E. Esveldt has authored 13 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Genetics. Recurrent topics in R. E. Esveldt's work include Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). R. E. Esveldt is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (8 papers) and Chronic Lymphocytic Leukemia Research (5 papers). R. E. Esveldt collaborates with scholars based in Netherlands, United States and United Kingdom. R. E. Esveldt's co-authors include Niek de Vries, Marieke E. Doorenspleet, Antoine H. C. van Kampen, Frank Baas, Barbera D. C. van Schaik, Daniëlle M. Gerlag, Paul P. Tak, P. L. Klarenbeek, Maria J. H. de Hair and Paul L. Klarenbeek and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Journal of Virology.

In The Last Decade

R. E. Esveldt

12 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. E. Esveldt Netherlands 9 298 107 84 84 68 13 414
Jennifer Pieper Sweden 8 298 1.0× 199 1.9× 80 1.0× 116 1.4× 83 1.2× 10 551
Junji Otsuka Japan 7 212 0.7× 116 1.1× 81 1.0× 48 0.6× 53 0.8× 14 393
Takashi Namekawa Japan 9 451 1.5× 118 1.1× 65 0.8× 68 0.8× 77 1.1× 10 617
Gábor Hutás United States 9 164 0.6× 74 0.7× 28 0.3× 63 0.8× 39 0.6× 9 349
Mikhail Olferiev United States 6 260 0.9× 160 1.5× 26 0.3× 59 0.7× 77 1.1× 11 388
Xin Ding Germany 10 453 1.5× 130 1.2× 26 0.3× 54 0.6× 92 1.4× 13 557
Mandar Bawadekar United States 12 343 1.2× 136 1.3× 70 0.8× 45 0.5× 63 0.9× 13 533
Hugo R. Scherbarth Argentina 4 170 0.6× 247 2.3× 46 0.5× 88 1.0× 26 0.4× 4 357
Yumiko Kanno Japan 12 464 1.6× 55 0.5× 39 0.5× 53 0.6× 64 0.9× 19 624
Line Ohm‐Laursen Denmark 8 246 0.8× 37 0.3× 28 0.3× 54 0.6× 110 1.6× 11 391

Countries citing papers authored by R. E. Esveldt

Since Specialization
Citations

This map shows the geographic impact of R. E. Esveldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Esveldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Esveldt more than expected).

Fields of papers citing papers by R. E. Esveldt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. E. Esveldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Esveldt. The network helps show where R. E. Esveldt may publish in the future.

Co-authorship network of co-authors of R. E. Esveldt

This figure shows the co-authorship network connecting the top 25 collaborators of R. E. Esveldt. A scholar is included among the top collaborators of R. E. Esveldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. E. Esveldt. R. E. Esveldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Doorenspleet, Marieke E., R. E. Esveldt, A. Elisabeth Hak, et al.. (2019). IgG4:IgG RNA ratio differentiates active disease from remission in granulomatosis with polyangiitis: a new disease activity marker? A cross-sectional and longitudinal study. Arthritis Research & Therapy. 21(1). 43–43. 6 indexed citations
2.
Klarenbeek, Paul L., Marieke E. Doorenspleet, Barbera D. C. van Schaik, et al.. (2019). Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire. Annals of the Rheumatic Diseases. 78(10). 1339–1345. 23 indexed citations
3.
Musters, Anne, Paul L. Klarenbeek, Marieke E. Doorenspleet, et al.. (2018). In Rheumatoid Arthritis, Synovitis at Different Inflammatory Sites Is Dominated by Shared but Patient-Specific T Cell Clones. The Journal of Immunology. 201(2). 417–422. 27 indexed citations
4.
Klarenbeek, P. L., Marieke E. Doorenspleet, Barbera D. C. van Schaik, et al.. (2018). THU0027 Non-response to rituximab therapy in reumatoid arthritis associates with incomplete disruption of the b-cell receptor repertoire in the peripheral blood. Annals of the Rheumatic Diseases. 77. 241–241.
5.
Schaik, Barbera D. C. van, Paul L. Klarenbeek, Marieke E. Doorenspleet, et al.. (2017). Computational Model Reveals Limited Correlation between Germinal Center B-Cell Subclone Abundancy and Affinity: Implications for Repertoire Sequencing. Frontiers in Immunology. 8. 221–221. 12 indexed citations
6.
Doorenspleet, Marieke E., Liset Westera, Charlotte P. Peters, et al.. (2017). Profoundly Expanded T-cell Clones in the Inflamed and Uninflamed Intestine of Patients With Crohn’s Disease. Journal of Crohn s and Colitis. 11(7). 831–839. 27 indexed citations
7.
Klarenbeek, Paul L., Marieke E. Doorenspleet, R. E. Esveldt, et al.. (2015). Somatic Variation of T-Cell Receptor Genes Strongly Associate with HLA Class Restriction. PLoS ONE. 10(10). e0140815–e0140815. 18 indexed citations
8.
Remmerswaal, Ester B. M., Paul L. Klarenbeek, Nuno L. Alves, et al.. (2014). Clonal Evolution of CD8+T Cell Responses against Latent Viruses: Relationship among Phenotype, Localization, and Function. Journal of Virology. 89(1). 568–580. 25 indexed citations
9.
Musters, Annelie H., Marieke E. Doorenspleet, P. L. Klarenbeek, et al.. (2014). AB0021 In Psoriatic Arthritis Synovial Tissue Harbors Expanded T-Cell Clones Which Are not Fully Represented in Synovial Fluid or Blood Samples. Annals of the Rheumatic Diseases. 73. 810–811. 1 indexed citations
10.
Doorenspleet, Marieke E., P. L. Klarenbeek, Maria J. H. de Hair, et al.. (2013). Rheumatoid arthritis synovial tissue harbours dominant B-cell and plasma-cell clones associated with autoreactivity. Annals of the Rheumatic Diseases. 73(4). 756–762. 85 indexed citations
11.
Klarenbeek, P. L., Maria J. H. de Hair, Marieke E. Doorenspleet, et al.. (2012). Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease. Annals of the Rheumatic Diseases. 71(6). 1088–1093. 104 indexed citations
12.
Klarenbeek, Paul L., Ester B. M. Remmerswaal, Ineke J. M. ten Berge, et al.. (2012). Deep Sequencing of Antiviral T-Cell Responses to HCMV and EBV in Humans Reveals a Stable Repertoire That Is Maintained for Many Years. PLoS Pathogens. 8(9). e1002889–e1002889. 85 indexed citations
13.
Klarenbeek, Paul L., Marieke E. Doorenspleet, Marieke M. J. Herenius, et al.. (2011). The T cell receptor repertoire in synovial tissue of patients with early rheumatoid arthritis (RA) is dominated by highly expanded clones, which is not the case in established RA. Annals of the Rheumatic Diseases. 70. A12–A13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Pieper Breakdown of academic impact, for papers by Junji Otsuka Breakdown of academic impact, for papers by Takashi Namekawa Breakdown of academic impact, for papers by Gábor Hutás Breakdown of academic impact, for papers by Mikhail Olferiev Breakdown of academic impact, for papers by Xin Ding Breakdown of academic impact, for papers by Mandar Bawadekar Breakdown of academic impact, for papers by Hugo R. Scherbarth Breakdown of academic impact, for papers by Yumiko Kanno Breakdown of academic impact, for papers by Line Ohm‐Laursen
Rankless by CCL
2026